vs
Idexx Laboratories（IDXX）与Titan Machinery Inc.（TITN）财务数据对比。点击上方公司名可切换其他公司
Idexx Laboratories的季度营收约是Titan Machinery Inc.的1.7倍（$1.1B vs $644.5M），Idexx Laboratories净利率更高（22.8% vs 0.2%，领先22.6%），Idexx Laboratories同比增速更快（14.3% vs -5.2%），过去两年Idexx Laboratories的营收复合增速更高（6.4% vs -13.0%）
IDEXX Laboratories是1983年成立的美国跨国企业，主营伴侣动物诊疗、畜禽养殖、水质检测、乳制品领域相关产品与服务的研发、生产及分销，总部位于缅因州韦斯特布鲁克，欧洲、中东及非洲地区分部设于荷兰霍夫多普。
泰坦机械是全球规模领先的农业与工程机械设备经销商，也是凯斯纽荷兰工业品牌最大的经销商之一，总部位于北达科他州西法戈，经营网点遍布美国中西部、澳大利亚、奥地利、保加利亚、德国、罗马尼亚及乌克兰，目前在纳斯达克挂牌上市，2023年总营收达22.09亿美元。
IDXX vs TITN — 直观对比
营收规模更大
IDXX
是对方的1.7倍
$644.5M
营收增速更快
IDXX
高出19.5%
-5.2%
净利率更高
IDXX
高出22.6%
0.2%
两年增速更快
IDXX
近两年复合增速
-13.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $644.5M |
| 净利润 | $248.2M | $1.2M |
| 毛利率 | 60.3% | 17.2% |
| 营业利润率 | 28.9% | 1.6% |
| 净利率 | 22.8% | 0.2% |
| 营收同比 | 14.3% | -5.2% |
| 净利润同比 | 14.8% | -30.1% |
| 每股收益（稀释后） | $3.09 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDXXTITN
| Q4 25 | $1.1B | $644.5M | ||
| Q3 25 | $1.1B | $546.4M | ||
| Q2 25 | $1.1B | $594.3M | ||
| Q1 25 | $998.4M | $759.9M | ||
| Q4 24 | $954.3M | $679.8M | ||
| Q3 24 | $975.5M | $633.7M | ||
| Q2 24 | $1.0B | $628.7M | ||
| Q1 24 | $964.1M | $852.1M |
净利润IDXXTITN
| Q4 25 | $248.2M | $1.2M | ||
| Q3 25 | $274.6M | $-6.0M | ||
| Q2 25 | $294.0M | $-13.2M | ||
| Q1 25 | $242.7M | $-43.8M | ||
| Q4 24 | $216.1M | $1.7M | ||
| Q3 24 | $232.8M | $-4.3M | ||
| Q2 24 | $203.3M | $9.4M | ||
| Q1 24 | $235.6M | $24.0M |
毛利率IDXXTITN
| Q4 25 | 60.3% | 17.2% | ||
| Q3 25 | 61.8% | 17.1% | ||
| Q2 25 | 62.6% | 15.3% | ||
| Q1 25 | 62.4% | 6.7% | ||
| Q4 24 | 59.8% | 16.3% | ||
| Q3 24 | 61.1% | 17.7% | ||
| Q2 24 | 61.7% | 19.4% | ||
| Q1 24 | 61.5% | 16.6% |
营业利润率IDXXTITN
| Q4 25 | 28.9% | 1.6% | ||
| Q3 25 | 32.1% | 0.1% | ||
| Q2 25 | 33.6% | -1.0% | ||
| Q1 25 | 31.7% | -6.0% | ||
| Q4 24 | 27.4% | 1.7% | ||
| Q3 24 | 31.2% | 2.5% | ||
| Q2 24 | 26.3% | 3.6% | ||
| Q1 24 | 31.0% | 4.8% |
净利率IDXXTITN
| Q4 25 | 22.8% | 0.2% | ||
| Q3 25 | 24.8% | -1.1% | ||
| Q2 25 | 26.5% | -2.2% | ||
| Q1 25 | 24.3% | -5.8% | ||
| Q4 24 | 22.7% | 0.3% | ||
| Q3 24 | 23.9% | -0.7% | ||
| Q2 24 | 20.3% | 1.5% | ||
| Q1 24 | 24.4% | 2.8% |
每股收益（稀释后）IDXXTITN
| Q4 25 | $3.09 | $0.05 | ||
| Q3 25 | $3.40 | $-0.26 | ||
| Q2 25 | $3.63 | $-0.58 | ||
| Q1 25 | $2.96 | $-1.92 | ||
| Q4 24 | $2.62 | $0.07 | ||
| Q3 24 | $2.80 | $-0.19 | ||
| Q2 24 | $2.44 | $0.41 | ||
| Q1 24 | $2.81 | $1.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.1M | — |
| 总债务越低越好 | $450.0M | $176.6M |
| 股东权益账面价值 | $1.6B | $612.6M |
| 总资产 | $3.4B | $1.8B |
| 负债/权益比越低杠杆越低 | 0.28× | 0.29× |
8季度趋势，按日历期对齐
现金及短期投资IDXXTITN
| Q4 25 | $180.1M | — | ||
| Q3 25 | $208.2M | — | ||
| Q2 25 | $164.6M | — | ||
| Q1 25 | $164.0M | — | ||
| Q4 24 | $288.3M | — | ||
| Q3 24 | $308.6M | — | ||
| Q2 24 | $401.6M | — | ||
| Q1 24 | $397.4M | — |
总债务IDXXTITN
| Q4 25 | $450.0M | $176.6M | ||
| Q3 25 | — | $164.5M | ||
| Q2 25 | — | $165.3M | ||
| Q1 25 | — | $168.7M | ||
| Q4 24 | $617.8M | $140.6M | ||
| Q3 24 | — | $126.6M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $120.1M |
股东权益IDXXTITN
| Q4 25 | $1.6B | $612.6M | ||
| Q3 25 | $1.6B | $610.3M | ||
| Q2 25 | $1.5B | $605.4M | ||
| Q1 25 | $1.4B | $614.1M | ||
| Q4 24 | $1.6B | $668.2M | ||
| Q3 24 | $1.6B | $659.6M | ||
| Q2 24 | $1.6B | $662.6M | ||
| Q1 24 | $1.6B | $657.6M |
总资产IDXXTITN
| Q4 25 | $3.4B | $1.8B | ||
| Q3 25 | $3.4B | $1.9B | ||
| Q2 25 | $3.3B | $1.8B | ||
| Q1 25 | $3.2B | $1.8B | ||
| Q4 24 | $3.3B | $2.1B | ||
| Q3 24 | $3.4B | $2.2B | ||
| Q2 24 | $3.4B | $2.1B | ||
| Q1 24 | $3.4B | $2.0B |
负债/权益比IDXXTITN
| Q4 25 | 0.28× | 0.29× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | 0.39× | 0.21× | ||
| Q3 24 | — | 0.19× | ||
| Q2 24 | — | 0.18× | ||
| Q1 24 | — | 0.18× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $355.8M | $34.0M |
| 自由现金流经营现金流 - 资本支出 | $326.3M | — |
| 自由现金流率自由现金流/营收 | 29.9% | — |
| 资本支出强度资本支出/营收 | 2.7% | — |
| 现金转化率经营现金流/净利润 | 1.43× | 28.37× |
| 过去12个月自由现金流最近4个季度 | $1.1B | — |
8季度趋势，按日历期对齐
经营现金流IDXXTITN
| Q4 25 | $355.8M | $34.0M | ||
| Q3 25 | $402.3M | $43.7M | ||
| Q2 25 | $185.7M | $6.2M | ||
| Q1 25 | $238.0M | $126.5M | ||
| Q4 24 | $262.0M | $-8.8M | ||
| Q3 24 | $220.1M | $-15.0M | ||
| Q2 24 | $248.3M | $-32.4M | ||
| Q1 24 | $198.6M | $49.8M |
自由现金流IDXXTITN
| Q4 25 | $326.3M | — | ||
| Q3 25 | $371.2M | — | ||
| Q2 25 | $151.6M | — | ||
| Q1 25 | $207.9M | — | ||
| Q4 24 | $232.8M | — | ||
| Q3 24 | $192.0M | — | ||
| Q2 24 | $215.0M | — | ||
| Q1 24 | $168.3M | — |
自由现金流率IDXXTITN
| Q4 25 | 29.9% | — | ||
| Q3 25 | 33.6% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 20.8% | — | ||
| Q4 24 | 24.4% | — | ||
| Q3 24 | 19.7% | — | ||
| Q2 24 | 21.4% | — | ||
| Q1 24 | 17.5% | — |
资本支出强度IDXXTITN
| Q4 25 | 2.7% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 3.1% | — |
现金转化率IDXXTITN
| Q4 25 | 1.43× | 28.37× | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 0.63× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.21× | -5.15× | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | 1.22× | -3.43× | ||
| Q1 24 | 0.84× | 2.08× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
TITN
| Agriculture Segment | $420.9M | 65% |
| Sales Of Parts | $122.3M | 19% |
| Service Sales | $48.9M | 8% |
| Australia_segment | $29.9M | 5% |
| Rental And Other | $13.3M | 2% |
| Rental | $10.3M | 2% |
| Other Revenue | $1.1M | 0% |
